NDC 36987-1237

Oyster

Oyster

Oyster is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Oyster.

• Product ID: 36987-1237_398aea37-e253-4fd4-84ca-ca78367468b5
• NDC: 36987-1237
• Product Type: Human Prescription Drug
• Proprietary Name: Oyster
• Generic Name: Oyster
• Dosage Form: Injection, Solution
• Route of Administration: INTRADERMAL; SUBCUTANEOUS
• Marketing Start Date: 1972-08-29
• Marketing Category: BLA / BLA
• Application Number: BLA102192
• Labeler Name: Nelco Laboratories, Inc.
• Substance Name: OYSTER
• Active Ingredient Strength: 0 g/mL
• Pharm Classes: Non-Standardized Food Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [CS],Dietary Proteins [CS],Shellfish Proteins [EXT]
• NDC Exclude Flag: E
• Listing Certified Through: 2017-12-31

Packaging

NDC 36987-1237-4

50 mL in 1 VIAL, MULTI-DOSE (36987-1237-4)

• Marketing Start Date: 1972-08-29
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 36987-1237-1 [36987123701]

Oyster INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-1237-3 [36987123703]

Oyster INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-1237-2 [36987123702]

Oyster INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

NDC 36987-1237-4 [36987123704]

Oyster INJECTION, SOLUTION

• Marketing Category: BLA
• Application Number: BLA102192
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 1972-08-29
• Inactivation Date: 2019-10-21

Drug Details

Active Ingredients

Ingredient	Strength
OYSTER	.1 g/mL

OpenFDA Data

• SPL SET ID: 026f2f1e-71cf-47ab-a24d-66663ff98429
• Manufacturer:
  • Nelco Laboratories, Inc.
• UNII:
  • BKZ683617P
  • 76780GX08D
  • 7062I37LB3
  • ZB2SV6JJY5
  • 0WLY635722
  • 01695YPV36
  • WF621S7K14
  • 5JKY494U4L
• RxNorm Concept Unique ID - RxCUI:
  • 905479
  • 892506
  • 905345
  • 892564
  • 904543
  • 901282
  • 892595
  • 892546
  • 966805
  • 899433
  • 966978
  • 901375
  • 904599
  • 901290
  • 899751
  • 899937
  • 905489
  • 901397
  • 905329
  • 892542
  • 905365
  • 892613

Pharmacological Class

• Non-Standardized Food Allergenic Extract [EPC]
• Increased Histamine Release [PE]
• Cell-mediated Immunity [PE]
• Allergens [CS]
• Dietary Proteins [CS]
• Shellfish Proteins [EXT]

NDC Crossover Matching brand name "Oyster" or generic name "Oyster"

NDC	Brand Name	Generic Name
0268-6189	OYSTER	EASTERN OYSTER
22840-5774	Oyster	Crassostrea virginica
36987-1234	Oyster	Oyster
36987-1235	Oyster	Oyster
36987-1236	Oyster	Oyster
36987-1237	Oyster	Oyster
49288-0336	Oyster	Oyster